about
Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking ApproachA review and commentary on a sample of 15 UK guidelines for the drug treatment of Alzheimer's disease.Loss in late lifeNew drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy.Keeping pace with new technologies: systems needed to identify and evaluate them.Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.Development of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking.The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs.Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer's disease drug donepezil in general practice?--national postal survey.What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options.Experimental and clinical methods in the development of anti-Alzheimer drugs.New drug treatment for Alzheimer's disease: lessons for healthcare policy.Do you know about donepezil and succinylcholine?Use of computerized tomography by old age psychiatrists: an examination of criteria for investigation of cognitive impairment.Why the tolerance of potential harms? Research ethics in Alzheimer disease.Alzheimer's Disease and Medicinal Plants: An Overview.7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment--synthesis, biological evaluation and molecular modeling studies.Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.Ethics and the anti-dementia drugs.Emerging antidementia drugs: a preliminary ethical view.Ginkgo biloba and Memory: An Overview.Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease.Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment.Donezepil for dementia.Application of response surface methodology to optimize the extraction of acetylcholinesterase inhibitors from Rhodiola sachalinensis
P2860
Q28553027-30448344-3A2A-49F8-B7E1-601CF780E299Q33642590-9B96D13B-4AB4-4A6C-815C-3AA934DD8206Q33790064-859F220B-5525-4F77-873E-F8483C6DA2ABQ33792081-8FF93C01-62BE-4BA5-B34A-DE7AE3F8B51FQ33821429-655AF1A7-FB06-4C60-BE4C-BDAC585A999DQ34049885-64FDADC5-547F-4B0A-9B18-E1DF51F5AF15Q35206199-57BD6D73-A7DF-47AD-A32E-3ACAA96F9996Q36179047-37028BBB-2811-4D9B-B695-94477BE0388BQ36586613-EEA115F9-FBFC-4685-B566-4DA67AF9F60BQ37316556-E687707C-5FE0-4334-AEA0-6F495B1FA12CQ40518584-55E4B21F-3F8C-411D-91CB-0CD8F5211ABFQ40826738-DE1576DF-8341-4272-9A11-2DAA0D5ECF72Q41729907-4C10F12D-6B29-4C9E-8ED2-CBAD60074680Q41732652-95EB6D97-E3CE-44EA-840B-C58658BEFB81Q44163567-AFBB4D94-F227-4DE8-BC2C-8A85DBD1305BQ48140939-97FE454F-C210-4EB8-ACE4-95E3616FB12CQ48659665-F49FC25C-2EEF-4C61-B345-199C2CC7AF81Q50145973-2B408730-A3EC-4A93-94AC-25CAA8FCBE93Q51829717-2628DCEB-8D2B-40D9-AD92-644DAF48209AQ51974558-8703CC97-C556-4DF4-9663-6CE285FA5916Q51976581-A146A1B8-6B35-4571-873F-5A222CBF64CCQ51993553-C83C4485-9F40-48F1-A6A2-EE98C26744FFQ51997416-9E8273F8-7C3A-46FE-9DAF-AE696757E671Q53335629-922CDADE-A7AB-4F3B-AB5D-E980C483EF8BQ53432582-D986221D-9B00-4D43-8AD6-2C41E10199E6Q55110440-8973396B-9DE5-4D49-8AF1-5DF2360882D7Q57440194-9126B305-DD08-4CF8-AF02-D772EB123AB0
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Drug treatments for Alzheimer's disease
@en
Drug treatments for Alzheimer's disease
@nl
type
label
Drug treatments for Alzheimer's disease
@en
Drug treatments for Alzheimer's disease
@nl
prefLabel
Drug treatments for Alzheimer's disease
@en
Drug treatments for Alzheimer's disease
@nl
P2093
P356
P1433
P1476
Drug treatments for Alzheimer's disease
@en
P2093
P304
P356
10.1136/BMJ.314.7082.693
P407
P577
1997-03-01T00:00:00Z